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Abstract

Introduction

The effects of individual glycosaminoglycan (GAG)
species on calcium oxalate monohydrate (COM) crystal
growth were studied in vitro by the observation of crystal morphology grown in a supersaturated calcium oxalate solution in the presence of GAGs using optical and
scanning electron microscopes. GAGs affected the
morphology of COM crystals differently depending on
the species. The growth rates of the crystals formed in
the presence of chondroitin-6-sulfate (ChS-C) were higher in length and lower in width and thickness than those
of control crystals. The incorporation of dermatan sulfate or heparin into the crystals formed in the presence
of these GAGs was revealed by X-ray microanalysis ,
whereas ChS-C was not detected in the crystals grown
with it. The experiment using dicarboxylates, as a
simple model of GAG molecules , showed that a distance
between the side groups was important for their morphological effects. These findings suggested that the different effects of GAGs on the crystal morphology resulted
from the differences in their interaction modes with
COM crystal faces, that is, the differences in their binding behavior, their inhibition modes of crystal growth,
and other roles played after binding to the crystals.

Glycosaminoglycans (GAGs) are known to be inhibitors of in vitro calcium oxalate (CaOx) crystallization as
well as urinary CaOx stone formation. GAGs have carboxyl and sulfate (except in hyaluronic acid) groups that
enable them to bind to calcium ions in solution and to
the surface of calcium-containing crystals. However,
GAGs concentrations in urine, as well as those used in
in vitro experiments, are too low to cause a significant
reduction of calcium in solution. Therefore, GAGs are
expected to exert inhibition through a mechanism by
binding to the crystals. Nevertheless, the extensive in
vitro studies about the inhibitory effects of GAGs on the
CaOx crystallization have employed indirect measurement methods; only a few of those papers have reported
on the resulting crystals (3, 9, 14]. Moreover, the inhibitory effects of GAGs and the mechanism underlying
these effects still remain unclear because diverse experimental model systems have been used; also, there is uncertainty in the literature about the target crystal form,
CaOx-monohydrate (COM), -dihydrate (COD) or a mixture of them, and the crystallization processes (nucleation, growth or aggregation of crystals). Hence, our
studies have been directly focused on COM crystals. By
using a mild condition, a gentle shaking instead of stirring, we could grow highly reproducible COM crystals
with characteristic morphology depending upon additives
and their concentrations [15, 16, 17, 18, 19, 20]. The
changes in morphology of COM crystals seemed to be
a consequence of the inhibition of crystal growth through
the interactions between GAG molecules and COM crystals. In this paper, we review these recent studies and
discuss the interaction modes between GAG molecules
and COM crystals.
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Materials and Methods
Crystal formation in vitro was performed under conditions close to the in vivo situation: 37°C, pH 5.7 and
physiological ionic strength under gentle shaking. Reagent grade chemicals and high purity water (15 MO.cm
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Figure 2 (on the facing page). Scanning electron
micrographs of COM crystals formed in the presence of
30 µglml individual GAGs. (A) HA; (B) ChS-C; (C)
ChS-A; (D) DS; (E) HS_;_ (F) HP. The top part of each
figure shows an upper (101) face view of a crystal and
the bottom part shows a side (010) face view of another
crystal. The morphology of these crystals differs from
each other. Bars = 10 µm.

Results and Discussion
Morphological effects of GAGs on COM crystals
COM crystals grown in the supersaturated CaOx
solutions in the presence or absence of GAGs were
observed by optical microscopy and SEM. They show
a wide variety of crystal forms such as hexagonal plates,
interpenetrating twins, mulberry, and aggregates.
Figure 1 shows the control crystals of COM, grown
in the absence of additives; these are the jominant
forms. They have an elongated hexagonal (101) face
and a double nock (010) face with reentrant comers, indicating its contact twin which is also evidenced by four
divisions observed under polarized light. Consequently,
these crystals do not appear to be real single crystals in
a crystallography sense, but in our papers, we have
treated them as "single crystals" and observed changes
in their morphology caused by additives.
Addition of GA Gs affected the morphology of COM
crystals; the results showed characteristic shapes which
varied with different types of GAGs. The morphological effects of increasing GAGs concentrations from 1 to
100 µglml were very pronounced: the crystals decreased
in thickness, suggesting that GAGs inhibit crystal growth
[15, 16, 18, 19]. Figure 2 shows scanning electron rnicrographs of the crystals formed by addition of different
GAGs at concentrations of 30 µglml .
In the presence of low concentrations (1 µg/ml) of
hyaluronic acid (HA), the crystals showed hexagonal
morphology very similar to the control crystal; but at
higher concentrations (100 µglml), the morphology of
the crystals was dramatically altered to fine and thin
lamellae (results not shown).
The crystals formed in the presence of chondroitin6-sulfate (ChS-C), at all concentrations, showed the
more elongated shape along the [101] direction and the
disappearance of the reentrant comers of the twins;
Figure 2B presents a typical example for a ChS-C concentration of 30 µglml. This morphology appears to result from the enhancement of crystal growth along the
[101] direction, especially at the reentrant comers.
The presence of chondroitin-4-sulfate (ChS-A) produced less elongated crystals habits (Fig. 2C) than in the
case of ChS-C (Fig. 2B).

Figure 1. Differential interference micrograph of typical COM crystals formed in supersaturated CaOx solution without ~y additives , as control crystals of COM.
Left, upper (101) face view of crystal with a hexagonal
face elongated along [101] direction. Right, side (010)
face view of other COM crystal with a double nock face
divided four areas under polarized light. Bar = 10 µm.
resistance) were used. Stock solutions of calcium chloride, sodium oxalate, GAGs and dicarboxylates were
prepared using 50 mM sodium acetate buffer (pH 5.7)
containing 0.1 M sodium chloride and were filtered
through a 0.22 µm Millipore filter. Four ml of 10 mM
calcium chloride stock solution, appropriate volumes of
additive stock solution and acetate buffer (to bring total
volume to 9 ml) were added in a plastic well (35 mm diameter), containing a few small glass plates, and were
preincubated for 30 minutes at 37°C. Then, one ml of
2 mM sodium oxalate stock solution was added slowly
to initiate crystallization which progressed under gentle
shaking with a rotary shaker at 37°C (except as noted
otherwise). In our experiments, supersaturated solutions
of CaOx initially contained 4 mM calcium and 0 .2 mM
oxalate in the acetate buffer, so that the initial molar
concentration product and the ionic strength of the solutions were 0.8 x 10-6 M 2 and 0.162, respectively. COM
crystals grown in the well were observed by Normaski
differential interference microscopy (OLYMPUS IMT2
NIC) and micrographs were taken at regular intervals.
After 5 to 6 days, the glass plates on which the crystals
formed were removed, washed with deionized-distilled
water several times, and air-dried. Finally, the specimens were either coated with gold/palladium (10 nm in
thickness) for scanning electron microscopy (SEM, using
a HITACHI S-800) or coated with carbon (20 to 30 nm
thick) for X-ray microanalysis (using a Kevex 7000
energy dispersive X-ray microanalyzer attached to a
HITACHI H-500 SEM). The crystals formed in this experiment were examined by X-ray powder diffraction
analysis (Rigaku Denki RINT 1300).
1082
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Table l. Atomic percentages of Sand Ca of COM crystals formed in the presence of diverse GAGs at concentrations
of 10 µg/ml (statistics: Student's t-test; mean ± standard deviation, SD).
Elements

Heparin

Dermatan sulfate

Chondroitin 6-sulfate

Hyaluronic acid

s (%)

2.16 ± 0.77"'

1.25 ± 0.17"'

0.47 ± 0.31

0.58 ± 0.26

97.83 ± 0.75

98.75 ± 0. 17

99.53 ± 0.27

99.47 ± 0.27

Ca(%)

. :p

< 0.001 versus hyaluronic acid.
ly binds to the crystal surface and is readily removed
from it, so ChS-C is not retained in a detectably significant amount in the crystals. That may be the reason
why ChS, the most prominent urinary GAG, is notably
absent from urinary stone matrix [13) . _ On the other
hand, DS and HP intimately bind to the (101) faces, resulting in their incorporation into the growing crystals
through the following mechanism: both GAGs bound to
the faces might offer the new nucleation sites and induce
oriented crystal nucleation on the faces; thus, they are
retained between all stratified crystallites and accumulate
in the crystals. These GAGs appear to be able to act not
only as growth inhibitors when present in solution, but
also as promoters of nucleation when immobilized onto
surfaces, as reported in other papers [1, 4, 5], where the
dual effect of several molecules, depending on the environment, was mentioned. That may be the possible
mechanism of development of the polycrystalline
aggregates.
X-ray powder diffraction analysis of the COM crystals grown in the presence of HP or ChS-C was performed. The diffraction intensity of the crystals with
HP was much weaker than that with ChS-C, which may
also reflect the different interaction modes mentioned
above (results not shown).
Individual GAG species have their own chemical
names , however, there are only a few differences in
their molecular structures, such as the number and location of sulfate groups and the stereoisomerical components of their disaccharide units. Nevertheless, they
affected COM morphology differently; therefore, their
ability to influence COM crystals seems to relate to the
stereochemical structures and the spatial arrangement of
carboxyl, sulfate and hydroxyl side groups along the
chains. Then, in the next step, the influence of differences in molecular structure of GAGs on COM morphology was studied by using dicarboxylates such as
malonate, maleate, fumarate, malate and succinate.
Malonate, maleate and malate affected the crystal morp_!iology, that is, the changes in the elongated hexagonal
(101) faces to rectangular ones (Figs. 3A, 3B and 3C),
whereas the rest of the dicarboxylates did not alter the
hexagonal morphology of the faces (Figs. 3D and 3E) .

The morphology of crystals in the presence of dermatan sulfate (DS) or heparan sulfate (HS) showed hexagonal plates with slightly rounded vertices and several
layers of lamellae. Their side (010) face views show
distinguishable features that are thinner layers with DS
(Fig. 2D) and a thick (010) face with HS (Fig. 2E).
In the presence of heparin (HP), COM cry~tals were
much smaller in size and appeared as oval {(101) face
view} and dumbbell {(010) face view} shapes consisting
of stacks of lamellar crystallites (Fig. 2F); these features
were evident even at low concentrations of 10 µg/ml (results not shown). These crystal shapes are similar to
those observed in urine [23) . They seem to be polycrystalline aggregates resulting from irregularities in crystal
growth but not as a result of aggregation of pre-existing
crystals.
Mechanism of interactions between GAGs and COM
crystals
The feature of the COM crystal morphology , mentioned above, led us to the following speculations: (1)
individual GAGs bind to the specific crystal faces with
different binding behaviors, the resulting retardation or
inhibition of the continuous crystal growth perpendicular
to these faces leads to differences in the crystal morphology; and (2) the differences in binding behaviors are
related to GAG molecule structures.
As a first step towards confirming the validity of
above speculations, X-ray microanalysis was performed
to determine whether the crystals contained sulfur derived from sulfate residues of GAGs: the results showed
that COM crystals formed in the presence of DS or HP
contained sulfur in the crystals; and also that, the
crystals grown with ChS-C contained the same amount
of sulfur as the crystals with non-sulfated HA (Table 1)
[18, 19). All GAGs, including ChS-C, must bind to
COM surfaces since they have been reported to shift the
zeta potential of CaOx crystals towards more negative
values [22] and also been reported to bind in the mode
of a monolayer type of adsorption [10). Since, X-ray
microanalysis detects the sum of emergent X-rays (by
incident electron beam) in a certain area and depth of the
crystals, these results may imply that ChS-C only loose1084
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Figure 4. Scanning electron micrograph of COM crystal grown in the presence of ChS-C (30 µg/ml), at
25°C, showing a dumbbell-shape with serrated ends and
reentrant comers (arrows). Bar = 10 µm.
Figure 3. Scanning electron micrographs of COM crystals grown with addition of several dicarboxylates at 10
mM except malate at 4 mM . (A) malonate; (B) malate;
(C) maleate; (D) fumalate ; (E) succinate. Crystal (101)
faces of upper panels have rectangular shapes, indicating
that malonate, malate and maleate affecte<l the crystal
morphology. Bar = 10 µm.

Table 2.
sulfates.•

location of
sulfate groups

ChS-C had a peculiar effect on COM crystal shapes,
the elongated morphology and the disappearance of reentrant comers of neat crystals. ChS-C was not detected
on the crystals by X-ray microanalysis even though it
contains the same amount of sulfur as DS . We became
specially interested in ChS in terms of its molecular
structure because L-iduronic acid in DS molecule and
D-glucuronic acid in ChS-C are stereoisomers. The effects of the number and location of sulfate groups in
ChS molecules on the crystal morphology were examined by using four types of ChS (-A, -C, -D and -E)
(Table 2).
Morphological features of the crystals
divided them into two groups, having mainly the ester
sulfate groups in the C-4 position or in the C-6 position
on the galactosamine (Figs. 2C and 2B). The ratio of
l~ngth {[101) direction} to width {[010] direction} on the
(101) face of the crystals in the case of the former
(ChS-A and -E) or the latter (ChS-C and -D) were 3.6
± 0.2 or 4.6 ± 0.3, respectively. The results indicate
that the location of sulfate groups plays more important
roles on the crystal shapes rather than the sulfate
contents in ChS molecules.
The morphological effect of ChS-C on the COM
crystal was changed by decreasing the experimental temperature to 25°C. The elongated morphology of the
crystals (Fig. 2B) changed to a dumbbell-shape with serrated ends and reentrant comers (Fig. 4) . The changes

sulfur
contents ( %)

ChS-A

Gal N

4-0 (80%),

6-0 (20%)

6.2 - 6.6

ChS-C

Gal N

4-0 (10%),

6-0 (90%)

6.4 - 6.8

GlcA

2-0 (30%),

Gal N
ChS-E

The effects of ChS on the COM crystal morphology
and growth

Molecular structure of four chondroitin

component

ChS-D

the side groups in GAG molecules might have the specific arrangements which depend on the GAG species,
that cause differences in binding behaviors.

Gal N

7.1 - 7.7
6-0 (100%)

4-0 (100%), 6-0 (60%)

8.2 - 9.0

*Data from Seikagaku Kogyo Co., Ltd. (Japan)
These results demonstrate that the appropriate distance
between two carboxyl groups is required for them to
cause morphological effects, and that a hydroxyl group
also plays a part as a binding site [20), while Grases et
al. [8) have related the hydroxyl groups to the molecular
rigidity. Their interactions with COM faces were probably through cooperative binding of both carboxyl groups
[11) and/or carboxyl and hydroxyl groups. Therefore,
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µm

length

width

thickness
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µm
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Figure 5. Effect of ChS on COM crystal growth. The sizes in length, width and thickness of the crystals formed in
the presence (solid circles) or absence (hollow squares) of ChS-C (100 µg/ml) were measured from the optical
photographs taken at indicated times after starting crystallization and plotted.

showed little change at any concentration of ChS-C,
which might be related to some possible biological functions of ChS which controls the crystal shapes [1].

in the conformation of ChS-C molecule and consequent
binding behavior to the crystals might occur because of
a change in temperature causing a conformational alteration of macromolecules [12] . This observation might
imply that the molecular conformation is one of the
important factors affecting crystal morphology [21] .
The effect of ChS-C on the COM crystal growth
was also determi_!led. The growth rates in length, width
and thickness {[101] direction} of the crystals were obtained from the optical photographs of the crystals taken
at 6, 12, 24, 48 and 72 hours after start of crystallization with or without ChS-C (Fig. 5). The results
showed a retardation of crystallization (nucleation and/or
growth) in the early stages, and a continuous enhancement (with a high rate) of crystal growth along the [101]
direction i!!_ the presence of ChS-C. The growth rates
along the [101] and [010] directions were lower in comparison with those of control crystals, resulting in relatively elongated. morphology . [20, Morepver, . q;i.s
bound to COM may exhibit a strong calcium-concentrating effect [2], increasing calcium concentrations around
the crystals, that could explain the continuous
enhancement of crystal growth along the [101] direction.
Toes~ findings suggest that ChS-C binds selectively to
the (101) and (010) faces, and consequently has a dual,
but quite the opposite, effect on the crystal growth
depending upon directions.
In addition, the elongated shape of neat crystals

Conclusions
Methods: Although the observation of the crystal
morphology is a very simple experiment, we can follow
the growth of COM crystals in vitro and observe resulting crystals direct! y. Our results indicate the importance
of direct observation. For example, the effect of ChS-C
may not be evaluated correctly by the Coulter counter
method because that method assumes the particles to be
spherical, whereas the crystals formed in the presence of
ChS-C are elongated. Any other method, besides direct
observation, cannot estimate such a dual effect of ChS-C
on the crystal growth depending on the directions. Conclusively, the careful observation of the crystal morphology is aQ. essenii~l me~hod an_d .can introduce_new .con- .
cepts into the studies.
Crystals: It is a well-known law that crystals consist of atoms with an orderly arrangement which is different in different faces. Especially, in the case of the
interactions involving crystal-surface-related processes,
the atomic arrangement of the interacting faces of COM
should be considered of great impor_!ance. There are coplanar calcium and oxalate in the (101) and (010) faces
of COM crystals [7]. According to Addadi and Weiner
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[l], however, the former face seems to be more interactive than the latter one. _ Therefore, GAGs might have
mainly bound to COM (101) face.
Moreover, in spite of having the same chemical
components, COM and COD are quite distinct substances in terms of crystallography, monoclinic and
tetragonal, respectively. The various morphologies of
COM crystals indicate that the crystal surfaces of COM
is susceptible to the influence of additives, whereas
COD crystal morphology appears identical regardless of
additives, suggesting that the COD crystal surface is
barely influenced by any of these substances [17] Thus,
the specific phase of CaOx, on which the effects of
GAGs were examined, should be stated clearly in order
to avoid confusion.
GAGs: GAGs in solution have been reported to
adopt random-coil conformations [6] However, the
highly reproducible morphology of COM crystals suggests that GAGs molecules at 37°C seem to adopt structural conformations, in which a certain set of the side
groups in the molecules may cooperatively take part in
binding to specific COM faces and the other set of them
may act as a nucleation site or exert a calcium-concentrating effect. Although the above stated mechanisms
are highly speculative, they should be taken into consideration for understanding the actual effects of GAGs. In
conclusion, we propose that GAGs might perform not
only inhibitory but also promotive roles in the crystalliz.ation processes.
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S. Deganello: The symmetry of the (101) is not
hexagonal. Please note that COM crystallizes in the
monoclinic system (P21/n or P21/c).
Authors: Although the word "hexagonal" may not be
an accurate one in crystallography, it is found in ~ y
papers as the morphological expressions of COM (101)
face (e.g., Campbell et al. (5], Antinozzi et al. (24]).
W.C. de Bruijn: What is the influence of the organic
to inorganic ratio on your Conclusions? Is it better, for
clarity of the process to estimate these ratios in terms of
mol/1 rather than as mg/ml since these GAGs are rather
large macromolecular complexes?
Authors: We wish to emphasize that the influence of
the organic components (GAGs) on the COM crystal
morphology depends more on their structural conformations rather than their concentrations. It is shown that
the increase in GAGs concentrations strengthens their
effect on the crystal morphology though.
Urinary concentrations of GAGs have been reported
in weight (µg/ml or mg/day) rather than on molar basis.
Moreover, these chemicals are commonly shown to have
a wide range of molecular weights in their explanations
(for example ChS-C: 4-8 x Hf). We, therefore, used
them in µg/ml basis, although it might be better to use
molar concentrations in the experiment.

Discussion with Reviewers
A.A. Campbell: Did the authors perform any modelling of the additives? There is much discussion about
stereochemistry and random-coil orientations without any
basis for making these assumptions. Assumptions are
made about specific binding of the additives to the crystals.
Any modelling to explore the additive
stereochemistry and internal spacing of functional groups
with the location of calcium ions on the respective
crystal faces?
Authors: We discuss the interaction modes based on
the stereochemical knowledge of GAG molecules and
also based on the results obtained from our experiments
using four types of ChS and dicarboxylates. We performed the modelling of the dicarboxylates and referred
to Deganello and Piro [6] for the crystal structures of
the COM faces.

W.C. de Bruijn: How were your experimental conditions related to urinary conditions?
Authors: The crystallization solutions were prepared
with physiological ionic strengths), pH 5.7 and within
the normal urinary concentrations of calcium and oxalate, and the crystallization took place at 37°C and under
a gentle shaking instead of a vigorous stirring which is
impossible in vivo but is ordinarily used in the in vitro
experiments.

A.A. Campbell: Is a calcium-rich crystal face important?
Authors: Yes, we think so and an interactive one is important as reported by Addadi and Weiner [1], as stated
in the Conclusions.
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F. Grases: It is stated that GAGs bound to the faces
might offer new nucleation sites and induce nucleation
on the faces forming polycrystalline aggregates. Could
this mechanism be responsible of COM primary aggregation during renal stone development?
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